24.12.2012 Views

Research Results - (PDF, 101 mb) - USAID

Research Results - (PDF, 101 mb) - USAID

Research Results - (PDF, 101 mb) - USAID

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

nymphs and adults. However, a high nu<strong>mb</strong>er<br />

of DNA extracts of nymphs fed as larvae and<br />

adults fed as nymphs on heartwater-infected<br />

goats bound to the DNA probes. Based on the<br />

relative specificity, we are currently pursuing<br />

the use of pCS20 in epidemiological and other<br />

studies. In addition, the DNA sequence is being<br />

determined so that the probe can be widely<br />

used. For instance, investigators in other countries<br />

can make synthetic oligonucleotide probes<br />

from the DNA sequence and not have to obtain<br />

the DNA probe.<br />

Project Achievements<br />

1. Development of a DNA probe for C.<br />

ruminantiumand detection of individual infected<br />

ticks.<br />

2. Completion of Dr. Suryakant Waghela's<br />

Ph.D. program.<br />

Changes in Workplan<br />

The focus on identification of surface<br />

proteins was temporarily interrupted in order to<br />

characterize the DNA probes to detect organisms.<br />

The primary reason was to complete Dr.<br />

Waghela's Ph.D. program.<br />

Activity No. 3. Contagious Caprne<br />

Pleuropneumonia (CCPP) Vaccine.<br />

Objective<br />

Immunize goats with expressed F38<br />

surfce einie tats with etra 3proteins g<br />

surface protein that reacts with neutralizing<br />

monoclonal antibody.<br />

Problem Statement and Approach<br />

CCPP is the most serious disease of goats<br />

in Kenya, causing high mortality and great<br />

economic loss. The disease occurs in epidemics<br />

in all areas of the country, including western<br />

Kenya. The SR-CRSP project and KARI developed<br />

an inactivated vaccine for CCPP. This<br />

vaccine is very effective and one dose induces<br />

protection for at least one year. All the SR-CRSP<br />

90<br />

goats and the KARI goats are routinely vaccinated.<br />

In addition, several hundred thousand<br />

doses of vaccine have been distributed to farmers<br />

in Kenya. There is a high demand for the<br />

vaccine by farmers and several million doses are<br />

needed. We continue to work with government<br />

and commercial sources to get more vaccine<br />

made.<br />

Since we have considerable experience<br />

with the CCPP system, it is a logical target for<br />

initial inclusion in a multivalent reco<strong>mb</strong>inant<br />

vaccine for goats. To this end, we are identifying<br />

F38 proteins expressed by reco<strong>mb</strong>inant organisms.<br />

Justification<br />

Delivery of individual monovalent<br />

vaccines, several of which are required to<br />

protect against the important goat diseases, is<br />

not possible in the case of farmers with a small<br />

nu<strong>mb</strong>er of goats and limited resources. Therefore,<br />

multivalent vaccines are needed and to<br />

incorporate CCPP antigens into a multivalent<br />

format, we are using reco<strong>mb</strong>inant DNA to<br />

obtain F38 surface proteins.<br />

Project Progress<br />

The plan was to use a monoclonal antibody<br />

developed by SR-CRSP that causes<br />

growth-inhibition of F38 to identify an F38<br />

surface protein expressed in a genomic DNA<br />

library. Initial experiments were done to verify<br />

that the monoclonal antibody bound to a protein<br />

epitope, providing a rationale for screening<br />

expressed by reco<strong>mb</strong>inant E.coli that<br />

are not glycosylated. The carbohydrate antigen<br />

that is used in the latex agglutination test was<br />

found to block the growth-inhibition caused by<br />

the monoclonal antibody. This indicated that<br />

the monoclonal antibody recognized a carbohydrate<br />

epitope and could not be used to screen<br />

the E.coli reco<strong>mb</strong>inants expressing F38 proteins.<br />

An antibody was needed that reacted<br />

with F38 surface proteins and could be used for<br />

immunoscreening. To obtain this antibody,<br />

large nu<strong>mb</strong>ers of F38 organisms were grown,<br />

isolated, and reacted with complement inacti­

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!